Request Deal Involvement

Suvretta Capital and SR One Capital led a $100m Series D round in Avalyn Pharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Deerfield Group Communications

pr advisors

Deerfield Group Communications

Thrust Strategic Communications

pr advisors

Thrust Strategic Communications

Cooley

legal advisors

Cooley

or

Principals

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

T ROWE PRICE ASSOCIATES INC

bidder

T ROWE PRICE ASSOCIATES INC

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

SR ONE CAPITAL MANAGEMENT

bidder

SR ONE CAPITAL MANAGEMENT

RIVERVEST VENTURE PARTNERS

bidder

RIVERVEST VENTURE PARTNERS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

AVALYN PHARMA INC

target

AVALYN PHARMA INC

SUVRETTA CAPITAL

bidder

SUVRETTA CAPITAL

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

PERCEPTIVE XONTOGENY VENTURE FUND

bidder

PERCEPTIVE XONTOGENY VENTURE FUND

NORWEST VENTURE PARTNERS

bidder

NORWEST VENTURE PARTNERS

TPG BIOTECHNOLOGY PARTNERS V

bidder

TPG BIOTECHNOLOGY PARTNERS V

EVENTIDE ASSET MANAGEMENT

bidder

EVENTIDE ASSET MANAGEMENT

HAMILTON SQUARE PARTNERS MANAGEMENT LP (HSQ)

bidder

HAMILTON SQUARE PARTNERS MANAGEMENT LP (HSQ)

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

VIDA VENTURES

bidder

VIDA VENTURES

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

PIVOTAL BIOVENTURE PARTNERS LLC

bidder

PIVOTAL BIOVENTURE PARTNERS LLC

ROCK SPRINGS CAPITAL

bidder

ROCK SPRINGS CAPITAL

TPG CAPITAL LP

bidder

TPG CAPITAL LP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite